Evidence for antimalarial policy and access: Business Plan 2008-2013
Most deaths due to malaria and other infectious diseases could be avoided with timely use of effective medicines, but this does not usually occur. New anti-malarial treatments are being developed and increased funds are being made available for Disease Endemic Countries (DEC) to deploy them. Countries need to make policy choices based on evidence produced under real life conditions. New methods of improving care delivery at the community level, and new strategies for integrating treatment for malaria and other common illnesses, must be developed in order to expand access to effective treatments. If Millennium Development Goals are to be met, there is an urgent need for research to address these elements through a coordinated research action, one that guides malaria treatment policy and develops treatment packages for malaria and other childhood infections close to where vulnerable groups live.
- Draft 26 June 2008 (after first Scientific Advisory Committee meeting); to be formally approved by TDR's Scientific and Technical Advisory Committee (STAC).